Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.2M 100.0% | $135K 100.0% | $0 | — | — |
| Cost of Revenue | $53K 4.3% | $0 0.0% | $0 | — | — |
| Gross Profit | $1.2M 95.7% | $135K 100.0% | $0 | — | — |
| Research & Development | $7.5M 609.2% | $9.1M 6744.4% | $6.0M | $2.5M | $2.8M |
| Selling, General & Admin | $5.8M 473.1% | $8.9M 6571.9% | $8.2M | $6.9M | $1.7M |
| Total Operating Expenses | $13.4M 1082.3% | $18.0M 13316.3% | $14.2M | $11.6M | $4.4M |
| Operating Income | -$12.2M -986.6% | -$17.8M -13216.3% | -$14.2M | -$11.6M | -$4.4M |
| Interest Expense | $31K 2.5% | $244K 180.7% | $1.1M | $630K | $212K |
| Interest & Investment Income | $325K 26.3% | $101K 74.8% | $0 | — | $12K |
| Other Income (Expense), net | $28K 2.3% | -$7.0M -5174.1% | -$12.0M | -$580K | -$148K |
| Pretax Income | -$12.1M -984.4% | -$24.8M -18390.4% | -$26.2M | -$12.2M | -$4.6M |
| Income Tax Expense | $3K 0.2% | $3K 2.2% | $0 | $1K | -$1K |
| Net Income | -$12.2M -984.6% | -$24.8M -18392.6% | -$26.2M | -$12.2M | -$4.6M |
| Per Share | |||||
| EPS (Basic) | $-5.86 | $-66.33 | $-30.26 | $-1.48 | $-0.63 |
| EPS (Diluted) | — | $-6.63 | $-30.26 | $-1.48 | $-0.63 |
| Weighted Avg Shares (Basic) | 2.1M | 374K | 867K | 8.2M | 7.2M |
| Weighted Avg Shares (Diluted) | — | 3.7M | 867K | 8.2M | 7.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
No current price collected.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cost of Revenue | — | — | — | 0.0 | 4.3 |
| Gross Profit | — | — | — | 100.0 | 95.7 |
| R&D | — | — | — | 6744.4 | 609.2 |
| SG&A | — | — | — | 6571.9 | 473.1 |
| Operating Income | — | — | — | -13216.3 | -986.6 |
| Income Tax | — | — | — | 2.2 | 0.2 |
| Net Income | — | — | — | -18392.6 | -984.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ICU: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 17 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.